Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BSQR
2551
DELISTED
BSQUARE Corporation
BSQR
| $1.12M | ﹤0.01% |
935,679
-1,300
| -0.1% | -$1.62K |
|
2552
Fuel Tech
FTEK
$45.6M
| $1.12M | ﹤0.01% |
1,133,251
+32,113
| +3% | +$34.3K |
|
2553
Iovance Biotherapeutics
IOVA
$2.95B
| $1.12M | ﹤0.01% |
+61,400
| New | +$1.36M |
|
2554
Cartesian Therapeutics
RNAC
$267M
| $1.11M | ﹤0.01% |
21,146
+5,429
| +35% | +$289K |
|
|
FRTX
2555
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $1.11M | ﹤0.01% |
5,892
+947
| +19% | +$217K |
|
2556
Limoneira
LMNR
$252M
| $1.1M | ﹤0.01% |
+60,200
| New | +$1.15M |
|
|
CYRN
2557
DELISTED
CYREN Ltd.
CYRN
| $1.1M | ﹤0.01% |
32,565
+127
| +0.4% | +$4.13K |
|
|
SGMA
2558
DELISTED
Sigmatron International
SGMA
| $1.09M | ﹤0.01% |
267,390
+23,861
| +10% | +$91.5K |
|
|
PENG
2559
Penguin Solutions Inc
PENG
$3.14B
| $1.08M | ﹤0.01% |
85,200
-143,000
| -63% | -$2.07M |
|
|
NAAS
2560
NaaS Technology Inc
NAAS
$57.5M
| $1.08M | ﹤0.01% |
16
+4
| +33% | +$271K |
|
2561
SIGA Technologies
SIGA
$210M
| $1.08M | ﹤0.01% |
211,600
+124,300
| +142% | +$670K |
|
|
CIVI
2562
DELISTED
Civitas Resources
CIVI
| $1.08M | ﹤0.01% |
+48,200
| New | +$1.07M |
|
2563
Forum Energy Technologies
FET
$959M
| $1.08M | ﹤0.01% |
34,817
+22,727
| +188% | +$934K |
|
2564
Navios Maritime Partners
NMM
$2.32B
| $1.08M | ﹤0.01% |
60,686
-131,863
| -68% | -$2.2M |
|
2565
iShares 10-20 Year Treasury Bond ETF
TLH
$10.8B
| $1.08M | ﹤0.01% |
7,200
-1,200
| -14% | -$176K |
|
2566
Mitek Systems
MITK
$869M
| $1.07M | ﹤0.01% |
111,289
-124,287
| -53% | -$1.24M |
|
2567
Microbot Medical
MBOT
$110M
| $1.07M | ﹤0.01% |
201,549
-5,338
| -3% | -$31.2K |
|
2568
Immersion
IMMR
$249M
| $1.06M | ﹤0.01% |
139,013
-16,700
| -11% | -$132K |
|
|
TGP
2569
DELISTED
Teekay LNG Partners L.P.
TGP
| $1.06M | ﹤0.01% |
77,732
-35,068
| -31% | -$523K |
|
|
CORV
2570
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $1.06M | ﹤0.01% |
528,975
-38,673
| -7% | -$78.3K |
|
2571
Lands' End
LE
$376M
| $1.06M | ﹤0.01% |
93,170
-37,200
| -29% | -$393K |
|
|
RAD
2572
DELISTED
Rite Aid Corporation
RAD
| $1.06M | ﹤0.01% |
152,100
+29,000
| +24% | +$208K |
|
2573
Eagle Bancorp Montana
EBMT
$188M
| $1.05M | ﹤0.01% |
60,032
+11,472
| +24% | +$192K |
|
|
MYND
2574
Mynd.ai
MYND
$17.4M
| $1.05M | ﹤0.01% |
16,364
+2,310
| +16% | +$148K |
|
2575
Beasley Broadcasting Group
BBGI
$41.6M
| $1.05M | ﹤0.01% |
16,910
+1,135
| +7% | +$71.6K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.